Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
For Canadians like Doran, the introduction of generics to Canada's market is "huge"
Key Milestones Timeline Eli Lillys Strategic Context Retatrutides development occurs within Eli Lillys broader metabolic disease portfolio, which also includes tirzepatide (approved as Mounjaro for type 2 diabetes and Zepbound for obesity) and orforglipron (an oral GLP-1R agonist in Phase 3 development)
Always follow your healthcare providers instructions and never replace one with the other without consulting a doctor
J Biol Chem 175:663674
In comparison, other GLP-1 agonists have also been beneficial, but some patients voice a distinct preference for semaglutide due to its once-weekly dosing convenience
Semaglutide Need help
US$ 22.45
US$ 25.65
US$ 27.50
US$ 28.16
US$ 27.31
US$ 22.97
